论文部分内容阅读
目的观察术中术后应用银杏达莫注射液治疗急慢性心梗患者的临床疗效。方法将40例急慢性心梗患者随机分为两组。治疗组20例采用银杏达莫注射液治疗,对照组使用低分子肝素钙治疗,观察比较两组临床疗效。结果总有效率治疗组为92.3%,对照组为69.0%,两组总有效率比较,差异有显著差异(P<0.05),治疗组疗效优于对照组。结论银杏达莫注射液是急慢性心肌梗塞非心脏手术麻醉较适合的术中术后治疗心梗的药物。
Objective To observe the clinical effect of intraoperative and postoperative application of gingkangdamo injection in patients with acute and chronic myocardial infarction. Methods Forty patients with acute and chronic myocardial infarction were randomly divided into two groups. The treatment group, 20 cases treated with gingko Damo injection, the control group using low molecular weight heparin treatment, the clinical efficacy of the two groups were observed and compared. Results The total effective rate was 92.3% in the treatment group and 69.0% in the control group. There was significant difference between the two groups in the total effective rate (P <0.05). The curative effect in the treatment group was better than that in the control group. Conclusion Ginkgo biloba injection is a suitable drug for postoperative myocardial infarction in patients undergoing non-cardiac surgery for acute and chronic myocardial infarction.